Skip to main content
OpenTrials
Completed

NCT Number: NCT03968965

Evaluation of 3D Machine-vision Image Guided Surgery Spine Navigation

This study assesses clinical outcomes following the use of the MvIGS spine navigation system for treatment of spinal stenosis and degenerative spondylolisthesis of the lumbar spine in adults. There will be separate study arms for cases utilizing the three-dimensional (3D) MvIGS spine navigation system and cases that utilize conventional two-dimensional (2D) fluoroscopy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital for Special Surgery

New York, 10021, United States

About this study

This is a single center, randomized, prospective cohort study to comparatively evaluate the implementation of the MvIGS spine navigation system to conventional 2D fluoroscopy for pedicle screw fixation for the treatment of spinal stenosis with degenerative spondylolisthesis of the lumbar spine. Fluoroscopy and the MvIGS navigation system are both intraoperative imaging options available to aid spine surgeons.

Fluoroscopy uses X-rays to obtain images of patient anatomy. The MvIGS spine navigation system provides patient specific, high quality intraoperative imaging with no radiation exposure. After the spine is exposed, intraoperative images are obtained using visible light then registered to the patient's preoperative computed tomography scan. Use of the proprietary integrated surgical light with embedded tracking technology and Instant Flash™ registration allows for continuous and direct visualization of the surgical field without disturbing surgeon workflow.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of spinal stenosis of the lumbar spine with ≤ grade 2 degenerative spondylolisthesis
  • Skeletally mature adults between the ages of 18-85 years at the time of surgery
  • Has completed at least 6 months of conservative therapy
  • Personally signed and dated informed consent document prior to any study-related procedures indicating that the patient has been informed of all pertinent aspects of the study

Exclusion criteria

  • Gross instability, defined as > 3 mm translational motion on flexion/extension studies
  • Degenerative spondylolisthesis > grade 2
  • Degenerative scoliosis > 10° at any level in lumbar spine
  • Congenital lumbar spinal stenosis
  • Endplate changes
  • Visible change in disc height
  • Radiographic confirmation of facet joint disease or degeneration
  • Prior surgery at any lumbar level including the level being treated except for: Lamino/Foraminotomy, Microdiscectomy, IDET, and Percutaneous Discectomy
  • Any evidence of a prior/current fracture, compromised vertebra, current or past trauma, or tumor at affected level or the spinous processes at the adjacent levels
  • Requires destabilizing surgical decompression that adversely affects the functioning of the facets
  • Cauda equina syndrome defined as neural compression causing neurogenic bowel (rectal incontinence) or bladder dysfunction (bladder retention or incontinence)
  • Significant peripheral neuropathy or acute denervation secondary to radiculopathy, caused by conditions other than spinal stenosis
  • Significant peripheral vascular disease (diminished dorsalis pedis or tibial pulses)
  • Morbid obesity, defined as BMI > 40 kg/m2
  • Active systemic or local infection
  • Active Hepatitis (receiving medical treatment within two years)
  • Immunocompromised such as but not limited to Acquired Immunodeficiency Syndrome (AIDS), HIV infection, Severe Combined Immunodeficiency Syndrome, Thymic Hypoplasia
  • Insulin dependent diabetes mellitus or any other medical condition(s) that would represent a significant increase in surgical risk or interfere with normal healing
  • Immunologically suppressed, or has received systemic steroids, excluding nasal steroids, at any dose daily for > 1 month within last 12 months
  • History of Paget's disease, osteomalacia, or any other metabolic bone disease
  • Active malignancy. A patient with a history of any invasive malignancy (except nonmelanoma skin cancer), unless treated with curative intent and there has been no clinical signs or symptoms of the malignancy >5 years
  • Involved in study of another investigational product that may affect outcome
  • Women who are pregnant, lactating or anticipate becoming pregnant within 24 months post-surgery
  • Patients who are incarcerated
  • Worker's compensation cases
  • Patients involved in active litigation relating to his/her spinal condition

Treatment and study plan

3D MvIGS Spine Navigation

Device

The 7D Surgical MvIGS spine navigation system is for spatial positioning and orientation of surgical instruments during pedicle screw implantation in patients undergoing posterior fixation in single or multiple levels. The surgical light containing the machine vision cameras is the sole luminaire during image guided surgery.

2D Fluoroscopy

Other

Pedicle screws will be placed using 2D fluoroscopy as the intraoperative imaging modality.

Primary outcomes

  1. Mean Total Length of Operative Time

    Time frame: Data captured up to four hours after end of surgery

    Operative time determined by the official recorded operative notes

Secondary outcomes

  1. Length of Stay

    Time frame: Data captured upon patient discharge.

    Length of hospital stay

  2. Estimated Blood Loss (EBL)

    Time frame: During surgery

    Blood loss during surgery

  3. Number of Misaligned Screws

    Time frame: During hospital admission after surgery, an average of approximately 14 days

    Number of screws that were misaligned as defined by discrepancies between the pilot hole and preoperative plan and final screw trajectory.

  4. Complications

    Time frame: During hospital admission after surgery, an average of approximately 14 days

    Number of reported complications (neurological deficits, dural tears, deep wound infections, etc.) while hospitalized

  5. Measurement of Radiation Exposure

    Time frame: During surgery

    Exposure measured by Dose Area Product (DAP)

  6. Radiation Exposure Time

    Time frame: During surgery

    Radiation exposure time

Sponsors and collaborators

Lead sponsor

7D Surgical Inc.

Industry

Collaborators

  • Hospital for Special Surgery, New York

Registry information

Official study title

A Single-Center, Prospective Cohort Study of the Machine-vision Image Guided Surgery (MvIGS) Spine Navigation System

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
May 30, 2019
Registry last updated
Nov 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.